Key result
Lobectomy and adjuvant ifosfamide-doxorubicin chemotherapy treat primary pulmonary synovial sarcoma in a 48-year-old male.
Case Report (n=1)
This case report highlights a rare presentation of primary synovial sarcoma of the lung.
Adds rare case to sparse literature on primary pulmonary synovial sarcoma; leaves open optimal regimens for prospective validation.
Synovial sarcoma of lung is a very rare tumor accounting for 0.5% of all primary lung malignancy. It presents clinically with cough, chest pain, shortness of breath, or hemoptysis, with a mass lesion on X-ray and computerized tomography scan. Diagnosis is made by histopathology and immunohistochemistry. Here, we report a case of 48-year-old male, who presented with right-sided chest pain, cough with blood-tinged sputum, and found to have primary pulmonary synovial sarcoma of lung.
No takes yet. Share an insight, caveat, or question.
Rajeev et al. (2017) conducted a case report in Primary synovial sarcoma of lung (n=1). Right upper lobectomy and adjuvant chemotherapy (ifosfamide and doxorubicin) was evaluated. A 48-year-old male with primary pulmonary synovial sarcoma was treated with right upper lobectomy and six cycles of adjuvant chemotherapy with ifosfamide and doxorubicin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: